November 10th 2011
Categories:
Biotech,
Biotech Services,
Biotechnology,
DNA,
Genetics,
Genome,
Medicine,
Microarrays,
Pharmaceuticals,
RNA,
Science
No Comments
St. Clair Shores, Michigan and Cambridge, Massachusetts – Michigan Institute of Urology, P. C. (MIU) and Cellay, Inc. today announced that MIU will exclusively perform a clinical trial for prostate cancer using Cellay's Same Day OligoFISH® probe panel. Data from this trial will be included in Cellay's premarket approval (PMA) ...
LC Sciences, a life sciences company leading the development of innovative microRNA (miRNA) analysis and discovery technologies, announced today the publication of over 250 peer-reviewed studies using the company’s microarray service for analyzing miRNA expression profiles. These studies, by leading researchers in the field, represent significant steps toward realizing these small ...
MicroTissues, Inc. announced today the launch of its 3D Petri Dish™ line of products. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery. Invented at Brown University, the 3D Petri Dish™ grows living human cells in three dimensions (3D) ...
MicroTissues, Inc. announced today that its 3D Petri Dish™ is targeted towards helping to reduce the numbers of animals used in research. The 3D Petri Dish™ is a new tool for the world wide industry of life sciences research and drug discovery that grows living cells in three dimensions (3D). These ...
MicroTissues, Inc. announced today that its 3D Petri Dish™ was used in one of Time magazine’s medical breakthroughs of 2010. Researchers at Brown University and Women and Infants Hospital used the 3D Petri Dish™ to invent the first artificial human ovary, a discovery important for fertility research and a possible infertility ...
Researchers from LC Sciences LLC and a collaboration of Universities1 have established a porcine microRNAome, a complete catalog of all microRNAs expressed in the species Sus scrofa2. MicroRNAs (miRNAs) are small regulatory RNA molecules known to control a wide array of cellular functions such as growth and development and whose ...
LC Sciences today announced the launch of its new Seq-Array(SM) services designed to take full advantage of both the latest deep sequencing capabilities and the proven genomics tool – microarray. This combination of technologies advances microRNA research to the next level of depth and understanding that was not possible before ...
Taking full advantage of its flexible µParaflo® Biochip Technology, Houston based LC Sciences today announced immediate availability of probe content from the newly created Plant MicroRNA Database (PMRD) for their microRNA (miRNA) microarray customers . This announcement comes immediately following a publication in Nucleic Acids Researchintroducing the public database 1 . ...
LC Sciences announced today the publication of the 100th peer-reviewed study by one of its customers using the company’s microarray service for analyzing microRNA (miRNA) expression profiles and for discovery of novel small RNAs. These studies, by leading researchers in the field, contribute to a fast growing body of knowledge defining ...
LC Sciences has announced the availability of a custom target enrichment service for next-generation sequencing applications. LC Sciences now provides a service for Target-Specific Selection of a defined genomic region (such as Mbp region at a specific location, suspected cancer regions, SNP regions, regions for genomic comparisons) or RNA sequences ...
October 27th 2008
Categories:
Biochemicals,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotechnology,
Gene,
Genetics,
Microarrays,
Pharmaceuticals,
Science
No Comments
Taking advantage of its flexible µParaflo™ Chip Technology, Houston based LC Sciences today announced immediate availability of probe content miRBase 10.0 for their microRNA (miRNA) microarray customers. This announcement comes less than a week after Sanger Institute’s update of their sequence database for known miRNAs (miRBase) 1 to version 10.0 (http://microrna.sanger.ac.uk/sequences). As the jump in
version numbers from ...
Applied Microarrays, Inc announced today the completion of Applied Microarrays' purchase of certain assets of GE Healthcare's CodeLink™ Gene Expression Bioarray System. Under the terms of the agreement, Applied Microarrays, Inc acquires certain equipment, inventory, licenses and assigned contracts associated with the CodeLink platform. Financial terms were not disclosed.
The transaction ...
August 29th 2008
Categories:
Biochemicals,
Biological Remediation,
Biomedical Engineering,
Biopharmaceutical,
Biotech,
Biotech Products,
Biotech Services,
Biotech Solutions,
Biotechnology,
Consulting,
DNA,
FDA,
Gene,
Gene Therapy,
Genetics,
Genome,
Healthcare,
Law,
Licenses,
Medical Technologies,
Medicine,
Microarrays,
Online,
Pharmaceuticals,
Policy,
Proteomics,
Regulations,
Science,
Tissue Engineering,
Vaccines
One Comment
EPR Biotech News is a new blog, part of EPR Network, that is going to be focused on and will be covering the biotech news and stories from press releases published on EPR Network.
EPR Network (EPR stands for express press release) is one of the nation’s largest press release distribution networks on Web. The EPR’s nationwide network includes 12 State based ...